Good News For Women With Newly-Diagnosed Ovarian Cancer — A Significant Increase in Survival Time With Promising New PARP Inhibitor Drugs

Published Sep 28, 2019

Good News For Women With Newly-Diagnosed Ovarian Cancer — A Significant Increase in Survival Time With Promising New PARP Inhibitor Drugs

A specific PARP inhibitor called Zejula more than doubled the amount of time that many women with ovarian cancer lived without their cancer getting worse.

NOW
PLAYING
Help Support the Amazing 10-Year-Old With a Rare Cancer Who Sold Her Art to Help With Her Medical Bills
NOW
PLAYING
Would You Buy These Potato Chips Instead of Another Snack Because They’re Pink? The Breast Cancer "Pinkwashing" Effect, Explained
NOW
PLAYING
Creativity & Help From Her Baby Girl Helped This Mom Stay 'Rock Solid' During Second Cancer, Leukemia
NOW
PLAYING
Cancer After 57 Days at Ground Zero: A Retired Firefighter Shares His 9/11 Story
NOW
PLAYING
Chemo During COVID-19: Survivors' Stories and Tips, Plus How Families Can Help
NOW
PLAYING
Continue Cancer Screenings Through COVID-19
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.